340 related articles for article (PubMed ID: 24325576)
1. Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design.
Yao X; Bunt C; Cornish J; Quek SY; Wen J
Chem Biol Drug Des; 2014 May; 83(5):560-75. PubMed ID: 24325576
[TBL] [Abstract][Full Text] [Related]
2. Oral Delivery of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Liposomes and Solid Lipid Particles: Improvement of Stability of Lactoferrin.
Yao X; Bunt C; Cornish J; Quek SY; Wen J
Chem Biol Drug Des; 2015 Oct; 86(4):466-75. PubMed ID: 25581616
[TBL] [Abstract][Full Text] [Related]
3. Stability of bovine lactoferrin in luminal extracts and mucosal homogenates from rat intestine: a prelude to oral absorption.
Yao X; Bunt C; Cornish J; Quek SY; Wen J
Chem Biol Drug Des; 2014 Dec; 84(6):676-84. PubMed ID: 24890384
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Cellular Uptake and Transport of Bovine Lactoferrin Using Pectin- and Chitosan-Modified Solid Lipid Nanoparticles.
Yao X; Bunt C; Liu M; Quek SY; Shaw J; Cornish J; Wen J
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631382
[TBL] [Abstract][Full Text] [Related]
5. Novel alginate-enclosed chitosan-calcium phosphate-loaded iron-saturated bovine lactoferrin nanocarriers for oral delivery in colon cancer therapy.
Kanwar JR; Mahidhara G; Kanwar RK
Nanomedicine (Lond); 2012 Oct; 7(10):1521-50. PubMed ID: 22734611
[TBL] [Abstract][Full Text] [Related]
6. Characterization of novel multifunctional cationic polymeric liposomes formed from octadecyl quaternized carboxymethyl chitosan/cholesterol and drug encapsulation.
Liang XF; Wang HJ; Luo H; Tian H; Zhang BB; Hao LJ; Teng JI; Chang J
Langmuir; 2008 Jul; 24(14):7147-53. PubMed ID: 18564860
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release.
Das S; Chaudhury A; Ng KY
Int J Pharm; 2011 Mar; 406(1-2):11-20. PubMed ID: 21168477
[TBL] [Abstract][Full Text] [Related]
8. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization.
Sankalia MG; Mashru RC; Sankalia JM; Sutariya VB
Eur J Pharm Biopharm; 2007 Feb; 65(2):215-32. PubMed ID: 16982178
[TBL] [Abstract][Full Text] [Related]
9. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations.
Das S; Ng KY; Ho PC
J Drug Target; 2011 Jul; 19(6):446-57. PubMed ID: 20684731
[TBL] [Abstract][Full Text] [Related]
10. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals.
Liu Y; Wang Y; Zhao J
Int J Biol Macromol; 2019 Mar; 124():667-680. PubMed ID: 30502425
[TBL] [Abstract][Full Text] [Related]
11. Effect of Membrane Surface Modification Using Chitosan Hydrochloride and Lactoferrin on the Properties of Astaxanthin-Loaded Liposomes.
Qiang M; Pang X; Ma D; Ma C; Liu F
Molecules; 2020 Jan; 25(3):. PubMed ID: 32019205
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
Liu Y; Luo X; Xu X; Gao N; Liu X
Int J Pharm; 2017 Jan; 517(1-2):1-7. PubMed ID: 27899320
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of clozapine through chitosan microparticles prepared by a novel method.
Agnihotri SA; Aminabhavi TM
J Control Release; 2004 Apr; 96(2):245-59. PubMed ID: 15081216
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of hydrophilic drug diclofenac sodium-loaded solid lipid nanoparticles based on phospholipid complexes technology.
Liu D; Chen L; Jiang S; Zhu S; Qian Y; Wang F; Li R; Xu Q
J Liposome Res; 2014 Mar; 24(1):17-26. PubMed ID: 24236407
[TBL] [Abstract][Full Text] [Related]
15. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
16. Drug release property of chitosan-pectinate beads and its changes under the influence of microwave.
Wong TW; Nurjaya S
Eur J Pharm Biopharm; 2008 May; 69(1):176-88. PubMed ID: 17980563
[TBL] [Abstract][Full Text] [Related]
17. Polymer coated liposomes for use in the oral cavity - a study of the in vitro toxicity, effect on cell permeability and interaction with mucin.
Klemetsrud T; Kjøniksen AL; Hiorth M; Jacobsen J; Smistad G
J Liposome Res; 2018 Mar; 28(1):62-73. PubMed ID: 27809639
[TBL] [Abstract][Full Text] [Related]
18. The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis.
Samarasinghe RM; Kanwar RK; Kanwar JR
Biomaterials; 2014 Aug; 35(26):7522-34. PubMed ID: 24933511
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
20. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study.
Zeng C; Jiang W; Tan M; Yang X; He C; Huang W; Xing J
Eur J Pharm Sci; 2016 Mar; 85():123-31. PubMed ID: 26883760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
